أعرض في EDS

Supplementary Tables from Impact of Neoadjuvant Durvalumab with or without Tremelimumab on CD8+ Tumor Lymphocyte Density, Safety, and Efficacy in Patients with Oropharynx Cancer: CIAO Trial Results

التفاصيل البيبلوغرافية
العنوان:	Supplementary Tables from Impact of Neoadjuvant Durvalumab with or without Tremelimumab on CD8+ Tumor Lymphocyte Density, Safety, and Efficacy in Patients with Oropharynx Cancer: CIAO Trial Results
المؤلفون:	Neil D. Gross, Bonnie S. Glisson, Maura L. Gillison, Andrew G. Sikora, J. Jack Lee, Faye M. Johnson, Jeffrey N. Myers, Adam S. Garden, Amy C. Hessel, Carla L. Warneke, Danice K. Torman, Yasir Y. Elamin, Jack Phan, Ryan P. Goepfert, Jason M. Johnson, Katherine A. Hutcheson, Maria L. Rubin, Diana Bell, Renata Ferrarotto
بيانات النشر:	American Association for Cancer Research (AACR), 2023.
سنة النشر:	2023
الوصف:	Supplementary Tables
DOI:	10.1158/1078-0432.22477680.v1
URL الوصول:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::93723b3a5978f3375277dafce6127683 https://doi.org/10.1158/1078-0432.22477680.v1
Rights:	OPEN
رقم الانضمام:	edsair.doi.dedup.....93723b3a5978f3375277dafce6127683
قاعدة البيانات:	OpenAIRE

الوصف
DOI:	10.1158/1078-0432.22477680.v1